Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients.

about

Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients.

Item

http://www.wikidata.org/entity/Q47202390

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Urinary Nerve Growth Factor as ...... n Overactive Bladder Patients.

@en

Urinary Nerve Growth Factor as ...... n Overactive Bladder Patients.

@nl

type

Item

label

Urinary Nerve Growth Factor as ...... n Overactive Bladder Patients.

@en

Urinary Nerve Growth Factor as ...... n Overactive Bladder Patients.

@nl

prefLabel

Urinary Nerve Growth Factor as ...... n Overactive Bladder Patients.

@en

Urinary Nerve Growth Factor as ...... n Overactive Bladder Patients.

@nl

P1476

Urinary Nerve Growth Factor as ...... in Overactive Bladder Patients

@en

P2093

Hyo Serk Lee

http://www.w3.org/2001/XMLSchema#string

Hyun Hwan Sung

http://www.w3.org/2001/XMLSchema#string

Kwang Jin Ko

http://www.w3.org/2001/XMLSchema#string

Kyu-Sung Lee

http://www.w3.org/2001/XMLSchema#string

Tae Heon Kim

http://www.w3.org/2001/XMLSchema#string

Won Jin Cho

http://www.w3.org/2001/XMLSchema#string

Yoon Seok Suh

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders.

Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function

Protein kinase C in cyclic stretch-induced nerve growth factor production by urinary tract smooth muscle cells.

The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor.

What is the role for biomarkers for lower urinary tract disorders? ICI-RS 2013.

Prevalence and burden of overactive bladder in the United States.

Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome

NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome

Biomarkers in overactive bladder: a new objective and noninvasive tool?

Swimming: effects on stress urinary incontinence and the expression of nerve growth factor in rats following transabdominal urethrolysis.

P304

270-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5213/INJ.1732794.397

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29298466

http://www.w3.org/2001/XMLSchema#string

P932

5756815

http://www.w3.org/2001/XMLSchema#string